Courier Therapeutics
St. Louis, United States
Overview
Courier Therapeutics developed a precision cytokine-delivery platform for cancer immunotherapy. Founded in 2015 by Dr. Alexander Krupnick and colleagues at Washington University in St. Louis, it was backed by BioGenerator Ventures and was acquired by Valo Health in 2021.
Key Facts
- Sector
- Biotech / Cancer Immunotherapy
Focus Areas
Biotech / Cancer Immunotherapy
Last updated July 27, 2026